Abstract: An electronic display comprises a support system comprising a plurality of support chassis, each support chassis comprising a plurality of chassis components each formed from one or more pieces of sheet metal, wherein the plurality of chassis components are welded together with a plurality of laser weld joints to form the support chassis having a front wall with a planar or substantially planar front mounting face, and a plurality of planar or substantially planar side walls, wherein the planar or substantially planar mounting faces of the plurality of support chassis are aligned to collectively form a front mounting surface, and a plurality of display modules mounted to the front mounting face, wherein each display module comprises an array of light-emitting element pixels, wherein the plurality of display modules collectively form a display surface.

Abstract: An electronic display comprises a support system comprising a plurality of support chassis, each support chassis comprising a plurality of chassis components each formed from one or more pieces of sheet metal, wherein the plurality of chassis components are welded together with a plurality of laser weld joints to form the support chassis having a front wall with a planar or substantially planar front mounting face, and a plurality of planar or substantially planar side walls, wherein the planar or substantially planar mounting faces of the plurality of support chassis are aligned to collectively form a front mounting surface, and a plurality of display modules mounted to the front mounting face, wherein each display module comprises an array of light-emitting element pixels, wherein the plurality of display modules collectively form a display surface.

Abstract: The invention is related to the process of fermentation with production strain Bacillus polymyxa for industrial production of antibiotic polymyxin B with yield from 1.8 to 2.8 g/l of filtrate of fermentation broth at temperature 28° C., pressure 40?70 kPa, aeration from 0.4 to 1 vvm, concentration of dissolved oxygen minimal 60%, maintenance of pH and optimal concentration of glucose and ammonium ions.

Abstract: The invention is related to the method of polymyxine B recovery from fermentation broth for the purpose of pure substance recovery. The invention mentioned above is obtained by using the method of polymyxine B recovery from fermentation broth according invention, which abstract is characterized by, that the filtrate is obtained from fermentation broth, its pH and color is adjusted and purified on non-ionogenic synthetic adsorbents of polystyrene type with specific surface 500 till 1000 m2·g?1 and fabric size 3 till 30 nm. The polymyxine B is eluated from adsorbent by aqueous solution of organic solvent. The polymyxine B base is coagulated from eluate after adjustment of pH to alcaline area. The polymyxine B base is converted by mineral acid to polymyxine B salt solution, from which is obtained crystal substance by drying.

Abstract: The invention is related to the method of polymyxine B recovery from fermentation broth for the purpose of pure substance recovery. The invention mentioned above is obtained by using the method of polymyxine B recovery from fermentation broth according invention, which abstract is characterized by, that the filtrate is obtained from fermentation broth, its pH and color is adjusted and purified on non-ionogenic synthetic adsorbents of polystyrene type with specific surface 500 till 1000 m2.g?1 and fabric size 3 till 30 nm. The polymyxine B is eluated from adsorbent by aqueous solution of organic solvent. The polymyxine B base is coagulated from eluate after adjustment of pH to alcaline area. The polymyxine B base is converted by mineral acid to polymyxine B salt solution, from which is obtained crystal substance by drying.

Abstract: The invention is related to the process of fermentation with production strain Bacillus polymyxa for industrial production of antibiotic polymyxine B with yield from 1.8 to 2.8 g/l of filtrate of fermentation broth at temperature 28° C., pressure 40-70 kPa, aeration from 0.4 to 1 vvm, concentration of dissolved oxygen minimal 60%, maintenance of pH and optimal concentration of glucose and ammonia ions.

Abstract: The invention solves a controlled release pharmaceutical composition containing tramadol hydrochloride, characterized in that it contains 100 to 200 mg of the active ingredient in admixture with micronized esters of glycerol with higher fatty acids, alkali salts of phosphoric acid, non-ionic vinylpyrrolidone polymers, substances from the group of salts of higher fatty acids with alkaline earth metals and silicon oxides and a method for the preparation of this composition.

Abstract: The invention involves a method of preparation of omeprazole by a reaction of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-1H-benzimidazole with peroxyacetic acid in a two-phase water and chlorinated organic solvent medium, in alkaline pH, subsequent separation of water and organic phases after the reaction and isolation of omeprazole from organic phase.